Clinical

High 5-year mortality in patients admitted with heart failure regardless of ejection fraction


 

Background: Heart failure with preserved EF is a common cause of inpatient admission and previously was thought to carry a better prognosis than heart failure with reduced EF. Recent analysis using data from Get With the Guidelines–Heart Failure (GWTG-HF) registry has shown similarly poor survival rates at 30 days and 1 year when compared with heart failure with reduced EF.

Study design: Multicenter retrospective cohort study.

Setting: 276 hospitals in the GWTG-HF registry during 2005-2009, with 5 years of follow-up through 2014.

Synopsis: A total 39,982 patients who were admitted for heart failure during 2005-2009 were included in the study with stratification into three groups based on ejection fraction; 18,398 (46%) with heart failure with reduced EF; 2,385 (8.2%) with heart failure with borderline EF; and 18,299 (46%) with heart failure with preserved EF. The 5-year mortality rate for the entire cohort was 75.4% with similar mortality rates for patient with preserved EF (75.3%), compared with those with reduced EF (75.7%).

Bottom line: Among patients hospitalized with heart failure, irrespective of their ejection fraction, the 5-year survival rates were equally dismal. Hospitalists may wish to use this information in goals of care discussions.

Citation: Shah KS et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017 Oct 31. doi: 10.1016/j.jacc.2017.08.074.

Dr. Miriam Gomez-Sanchez, a hospitalist at the University of Virginia Medical Center

Dr. Miriam Gomez-Sanchez

Dr. Gomez-Sanchez is a hospitalist at the University of Virginia Medical Center.

Recommended Reading

Use of a risk score may be able to identify high-risk patients presenting with acute heart failure
The Hospitalist
Warfarin dose capping avoided supratherapeutic INRs in hospitalized elderly
The Hospitalist
Short Takes
The Hospitalist
Any detectable high-sensitivity cardiac troponin T (hs-cTn) level is associated with adverse outcomes
The Hospitalist
Percutaneous coronary intervention (PCI) does not improve exercise time in patients with stable angina
The Hospitalist
Simvastatin, atorvastatin cut mortality risk for sepsis patients
The Hospitalist
Risk of ED visit/hospitalization increases when brand-name angiotensin receptor blockers (ARB) are switched to generic versions
The Hospitalist
The ‘holy grail’ of thrombosis prevention
The Hospitalist
From #MeToo to troponins: Updates in hospital medicine
The Hospitalist
Common infections are potent risk factor for MI, stroke
The Hospitalist
   Comments ()